Comment
Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? NO
[Article in
English,
French]
Affiliations
- PMID: 17872839
- PMCID: PMC1949246
Item in Clipboard
Comment
Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? NO
[Article in
English,
French]
Can Fam Physician.
2007 Aug.
No abstract available
Comment in
-
Beta-agonists: all the facts please.Can Fam Physician. 2007 Nov;53(11):1884-6; author reply 1886. Can Fam Physician. 2007. PMID: 18000257 Free PMC article. No abstract available.
Comment on
-
Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.Can Fam Physician. 2007 Aug;53(8):1290-7. Can Fam Physician. 2007. PMID: 17872838 Free PMC article. No abstract available.
Similar articles
-
Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? No.Can Fam Physician. 2007 Sep;53(9):1429-30, 1432. Can Fam Physician. 2007. PMID: 17872866 Free PMC article. No abstract available.
-
Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? Yes.Can Fam Physician. 2007 Sep;53(9):1429-30, 1432-3. Can Fam Physician. 2007. PMID: 17872865 Free PMC article. No abstract available.
-
Should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? YES.Can Fam Physician. 2007 Aug;53(8):1290-7. Can Fam Physician. 2007. PMID: 17872838 Free PMC article. No abstract available.
-
Long-acting beta(2) agonists as potential option in the treatment of acute exacerbations of COPD.Pulm Pharmacol Ther. 2003;16(4):197-201. doi: 10.1016/S1094-5539(03)00025-7. Pulm Pharmacol Ther. 2003. PMID: 12850121 Review. No abstract available.
-
Chronic obstructive pulmonary disease.Clin Evid. 2006 Jun;(15):2077-100. Clin Evid. 2006. PMID: 16973079 Review. No abstract available.
References
-
- O’Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Resp Crit Care Med. 2001;164:770–7. - PubMed
-
- O’Donnell DE, Aaron SD, Bourbeau J, Hernandez P, Marciniuk DD, Balter M, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease—2003. Can Respir J. 2003;10(Suppl A):11A–33A. - PubMed
-
- Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Crit Care Med. 2001;163:1256–76. - PubMed
-
- Sestini P, Renzoni E, Robinson S, Poole P, Ram FSF. Short-acting beta 2 agonists for stable COPD. Cochrane Database Syst Rev. 2002;3:CD001495. - PubMed
-
- O’Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J. 2004;24:86–94. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
